Allergy Therapeutics News and Activities

Allergy Therapeutics is a company listed under the stock ticker AGY (GB).

Allergy Therapeutics has a direct presence in 2 countries.

View the org chart displaying its 16 main executives

Most searched biographies at Allergy Therapeutics

• Manuel Llobet, Chief Executive Officer and Director
• David Ball, Independent Non-Executive Director
• Tunde Otulana, Non-Executive Director

Create your alert
to follow the executive moves at Allergy Therapeutics.

Allergy Therapeutics has 1,828 competitors including Pfizer (United States (USA)), Sanofi (France) and Johnson & Johnson (United States (USA)).

Popular M&A news in Pharmaceuticals

• Juvenescence has just announced a $76 Million fundraising (posted on May 22 2025).
• Kincell Bio has just announced a $22 Million fundraising (posted on May 22 2025).
• Danone has announced the acquisition of Kate Farms  (posted on May 14 2025).

Popular contacts in Pharmaceuticals

• Estelle Vester-Blokland - Senior Vice President, Medical and Head, International Markets at Bristol-Myers Squibb
• Seth Harrison - Chairman and Director at Braeburn Pharmaceuticals
• Fred Davenport - Lead Director at Medpace

Learn more about the Pharmaceuticals industry

Press releases by Allergy Therapeutics

Social media about Allergy Therapeutics

• Allergy Therapeutics on Wikipedia, Google News & Yahoo Finance
• Allergy Therapeutics on LinkedIn, Twitter & YouTube